NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1/CXCL8 axis
Article in Cancer Letters (April 2024)
The most recent citing publications are shown below. View all 70 publications that cite this research output on Dimensions.
Article in Cancer Letters (April 2024)
Article in Parasitology Research (December 2023)
Article in Cancers (November 2023)